Kristiina Iljin
Espoo, 02150, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Structural insight to elucidate the binding specificity of the anti-cortisol Fab fragment with glucocorticoids.
Journal: Journal of structural biology
Published: February 16, 2023
Functionalisation of Graphene Sensor Surfaces for the Specific Detection of Biomarkers.
Journal: Angewandte Chemie (International ed. in English)
Published: December 23, 2022
Correction to "Integration of Metabolomics and Expression of Glycerol-3-phosphate Acyltransferase (GPAM) in Breast Cancer─Link to Patient Survival, Hormone Receptor Status, and Metabolic Profiling".
Journal: Journal of proteome research
Published: June 01, 2022
Layered material platform for surface plasmon resonance biosensing.
Journal: Scientific reports
Published: September 08, 2019
Identifying the druggable interactome of EWS-FLI1 reveals MCL-1 dependent differential sensitivities of Ewing sarcoma cells to apoptosis inducers.
Journal: Oncotarget
Published: March 07, 2018
PLA2G7 associates with hormone receptor negativity in clinical breast cancer samples and regulates epithelial-mesenchymal transition in cultured breast cancer cells.
Journal: The journal of pathology. Clinical research
Published: January 02, 2017
High-throughput cell-based compound screen identifies pinosylvin methyl ether and tanshinone IIA as inhibitors of castration-resistant prostate cancer.
Journal: Journal of molecular biochemistry
Published: November 29, 2016
Retinoic acid and TGF-β signalling cooperate to overcome MYCN-induced retinoid resistance.
Journal: Genome medicine
Published: June 29, 2016
REG4 Is Highly Expressed in Mucinous Ovarian Cancer: A Potential Novel Serum Biomarker.
Journal: PloS one
Published: November 19, 2015
Integrative omics reveals MYCN as a global suppressor of cellular signalling and enables network-based therapeutic target discovery in neuroblastoma.
Journal: Oncotarget
Published: November 15, 2015
Wnt signalling is a bi-directional vulnerability of cancer cells.
Journal: Oncotarget
Published: November 03, 2015
Last Updated: 09/26/2026